Σερτραλίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Σερτραλίνη" in Greek language version.

refsWebsite

Global rank Greek rank

87nih.gov

4^th place

67doi.org

2^nd place

3^rd place

18archive.org

6^th place

5^th place

7fda.gov

447^th place

368^th place

6drugs.com

399^th place

130^th place

5web.archive.org

1^st place

3books.google.com

3^rd place

6^th place

2clincalc.com

3,912^th place

594^th place

1psychcentral.com

9,619^th place

8,766^th place

1nps.org.au

low place

1medscape.com

719^th place

579^th place

1webcitation.org

24^th place

77^th place

1cpa-apc.org

low place

1auckland.ac.nz

4,539^th place

low place

1medicinescomplete.com

low place

5,144^th place

1uptodate.com

3,771^st place

3,079^th place

1mhra.gov.uk

low place

1drugbank.ca

4,294^th place

4,484^th place

1unc.edu

1,538^th place

2,363^rd place

1harvard.edu

18^th place

57^th place

1cnn.com

28^th place

93^rd place

archive.org

«The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions». The Journal of Pharmacology and Experimental Therapeutics 316 (1): 336–48. January 2006. doi:10.1124/jpet.105.093229. PMID 16192315. https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2006-01_316_1/page/336.
«Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder». The American Journal of Psychiatry 160 (11): 1919–28. November 2003. doi:10.1176/appi.ajp.160.11.1919. PMID 14594734. https://archive.org/details/sim_american-journal-of-psychiatry_2003-11_160_11/page/1919.
«Rational treatment choices for non-major depressions in primary care: an evidence-based review». Journal of General Internal Medicine 17 (4): 293–301. April 2002. doi:10.1046/j.1525-1497.2002.10350.x. PMID 11972726. PMC 1495030. https://archive.org/details/sim_journal-of-general-internal-medicine_2002-04_17_4/page/293.
«Premature ejaculation: state of the art». The Urologic Clinics of North America 34 (4): 591–9, vii–viii. November 2007. doi:10.1016/j.ucl.2007.08.011. PMID 17983899. https://archive.org/details/sim_urologic-clinics-of-north-america_2007-11_34_4/page/591.
The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. 2012. ISBN 978-0-470-97948-8.
«Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment». The Journal of Clinical Psychiatry 61 (11): 863–7. November 2000. doi:10.4088/JCP.v61n1109. PMID 11105740. https://archive.org/details/sim_journal-of-clinical-psychiatry_2000-11_61_11/page/863.
«Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors». The Journal of Clinical Psychiatry 65 (10): 1365–71. October 2004. doi:10.4088/JCP.v65n1011. PMID 15491240. https://archive.org/details/sim_journal-of-clinical-psychiatry_2004-10_65_10/page/1365.
«Effects of sertraline on autonomic and cognitive functions in healthy volunteers». Psychopharmacology 168 (3): 293–8. July 2003. doi:10.1007/s00213-003-1448-4. PMID 12692706. https://archive.org/details/sim_psychopharmacology_2003-07_168_3/page/293.
«Cognitive performance in depressed patients after chronic use of antidepressants». Psychopharmacology 185 (1): 84–92. March 2006. doi:10.1007/s00213-005-0274-2. PMID 16485140. https://archive.org/details/sim_psychopharmacology_2006-03_185_1/page/84.
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th έκδοση). Arlington, VA: American Psychiatric Publishing. σελίδες 449. ISBN 9780890425558.
«Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis». JAMA Psychiatry 70 (4): 436–43. April 2013. doi:10.1001/jamapsychiatry.2013.684. PMID 23446732. https://archive.org/details/sim_jama-psychiatry_2013-04_70_4/page/436.
«CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations». Journal of Clinical Pharmacology 40 (1): 58–66. January 2000. doi:10.1177/00912700022008702. PMID 10631623. https://archive.org/details/sim_journal-of-clinical-pharmacology_2000-01_40_1/page/58.
«Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers». Journal of Clinical Psychopharmacology 27 (1): 28–34. February 2007. doi:10.1097/00004714-200702000-00005. PMID 17224709. https://archive.org/details/sim_journal-of-clinical-psychopharmacology_2007-02_27_1/page/28.
«Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [¹¹CDASB positron emission tomography study»]. The American Journal of Psychiatry 161 (5): 826–35. May 2004. doi:10.1176/appi.ajp.161.5.826. PMID 15121647. https://archive.org/details/sim_american-journal-of-psychiatry_2004-05_161_5/page/826.
«Relevance of endogenous 3α-reduced neurosteroids to depression and antidepressant action». Psychopharmacology 186 (3): 351–61. June 2006. doi:10.1007/s00213-005-0201-6. PMID 16249906. https://archive.org/details/sim_psychopharmacology_2006-06_186_3/page/351.
«The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin». Clinical Pharmacology and Therapeutics 60 (5): 512–21. November 1996. doi:10.1016/S0009-9236(96)90147-2. PMID 8941024. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_1996-11_60_5/page/512.
«Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19». Clinical Pharmacology and Therapeutics 70 (1): 42–7. July 2001. doi:10.1067/mcp.2001.116513. PMID 11452243. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2001-07_70_1/page/42.
Ciraulo, DA, επιμ. (2011). Pharmacotherapy of Depression (2nd έκδοση). New York, NY: Humana Press. ISBN 978-1-60327-434-0.

auckland.ac.nz

researchspace.auckland.ac.nz

«Selective serotonin reuptake inhibitors for premenstrual syndrome». The Cochrane Database of Systematic Reviews 6 (6): CD001396. June 2013. doi:10.1002/14651858.cd001396.pub3. PMID 23744611. PMC 7073417. https://researchspace.auckland.ac.nz/bitstream/2292/9631/4/14651858.CD001396.pub2.pdf.

books.google.com

Hubbard, John R.· Martin, Peter R. (2001). Substance Abuse in the Mentally and Physically Disabled. CRC Press. σελ. 26. ISBN 9780824744977.
Brown, Thomas E.· Brown, Thomas E. (2009). ADHD comorbidities: handbook for ADHD complications in children and adults. American Psychiatric Pub. ISBN 978-1-58562-158-3.
Hilal-Dandan, Randa· Brunton, Laurence (2013). Goodman and Gilman Manual of Pharmacology and Therapeutics (Second έκδοση). McGraw Hill Professional. σελ. 247. ISBN 978-0-07-176917-4.

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Sertraline Hydrochloride - Drug Usage Statistics». ClinCalc. 23 Δεκεμβρίου 2019. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Απριλίου 2020. Ανακτήθηκε στις 11 Απριλίου 2020.

cnn.com

money.cnn.com

Smith, Aaron (17 Ιουλίου 2006). «Pfizer needs more drugs». CNNMoney.com. Ανακτήθηκε στις 27 Ιανουαρίου 2007.

cpa-apc.org

server03.cpa-apc.org

«Pharmacotherapies in the management of obsessive-compulsive disorder». Canadian Journal of Psychiatry 51 (7): 417–30. June 2006. doi:10.1177/070674370605100703. PMID 16838823. Αρχειοθετήθηκε από το πρωτότυπο στις 4 February 2010. https://www.webcitation.org/5nIDpfMnA?url=http://server03.cpa-apc.org:8080/Publications/Archives/CJP/2006/june/cjp-june-06-blier-IR.pdf.

doi.org

dx.doi.org

«Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study». Drug Metabolism and Disposition 33 (2): 262–70. February 2005. doi:10.1124/dmd.104.002428. PMID 15547048.
«The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions». The Journal of Pharmacology and Experimental Therapeutics 316 (1): 336–48. January 2006. doi:10.1124/jpet.105.093229. PMID 16192315. https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2006-01_316_1/page/336.
«Clinical pharmacokinetics of sertraline». Clinical Pharmacokinetics 41 (15): 1247–66. 2002. doi:10.2165/00003088-200241150-00002. PMID 12452737.
«Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers». Journal of Clinical Psychopharmacology 24 (1): 4–10. February 2004. doi:10.1097/01.jcp.0000104908.75206.26. PMID 14709940.
«A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?». International Clinical Psychopharmacology 29 (4): 185–96. July 2014. doi:10.1097/YIC.0000000000000023. PMID 24424469.
«Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?». Psychotherapy and Psychosomatics 76 (1): 5–14. 2007. doi:10.1159/000096360. PMID 17170559.
«Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine». Health Technology Assessment 17 (7): 1–166. February 2013. doi:10.3310/hta17070. PMID 23438937.
«Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder». The American Journal of Psychiatry 160 (11): 1919–28. November 2003. doi:10.1176/appi.ajp.160.11.1919. PMID 14594734. https://archive.org/details/sim_american-journal-of-psychiatry_2003-11_160_11/page/1919.
«Pharmacotherapies in the management of obsessive-compulsive disorder». Canadian Journal of Psychiatry 51 (7): 417–30. June 2006. doi:10.1177/070674370605100703. PMID 16838823. Αρχειοθετήθηκε από το πρωτότυπο στις 4 February 2010. https://www.webcitation.org/5nIDpfMnA?url=http://server03.cpa-apc.org:8080/Publications/Archives/CJP/2006/june/cjp-june-06-blier-IR.pdf.
Pediatric OCD Treatment Study (POTS) Team (October 2004). «Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial». JAMA 292 (16): 1969–76. doi:10.1001/jama.292.16.1969. PMID 15507582.
«A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder». The Journal of Clinical Psychiatry 67 (7): 1133–9. July 2006. doi:10.4088/JCP.v67n0717. PMID 16889458.
«Sertraline in the treatment of anxiety disorders». Depression and Anxiety 11 (4): 139–57. 2000. doi:10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C. PMID 10945134.
«Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies». Archives of Women's Mental Health 9 (3): 151–7. May 2006. doi:10.1007/s00737-005-0111-y. PMID 16292466.
«Efficacy and tolerability of second-generation antidepressants in social anxiety disorder». International Clinical Psychopharmacology 23 (3): 170–9. May 2008. doi:10.1097/YIC.0b013e3282f4224a. PMID 18408531.
«Pharmacotherapy of social anxiety disorder: what does the evidence tell us?». The Journal of Clinical Psychiatry 67 Suppl 12: 20–6. 2006. doi:10.1016/j.genhosppsych.2005.07.002. PMID 17092192.
«Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety». The New England Journal of Medicine 359 (26): 2753–66. December 2008. doi:10.1056/nejmoa0804633. PMID 18974308.
«Selective serotonin reuptake inhibitors for premenstrual syndrome». The Cochrane Database of Systematic Reviews 6 (6): CD001396. June 2013. doi:10.1002/14651858.cd001396.pub3. PMID 23744611. PMC 7073417. https://researchspace.auckland.ac.nz/bitstream/2292/9631/4/14651858.CD001396.pub2.pdf.
«Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?». Drugs 62 (13): 1869–85. 2002. doi:10.2165/00003495-200262130-00004. PMID 12215058.
«Rational treatment choices for non-major depressions in primary care: an evidence-based review». Journal of General Internal Medicine 17 (4): 293–301. April 2002. doi:10.1046/j.1525-1497.2002.10350.x. PMID 11972726. PMC 1495030. https://archive.org/details/sim_journal-of-general-internal-medicine_2002-04_17_4/page/293.
«Pharmacologic treatment of rapid ejaculation: levels of evidence-based review». Current Clinical Pharmacology 1 (3): 243–54. September 2006. doi:10.2174/157488406778249352. PMID 18666749.
«Premature ejaculation: state of the art». The Urologic Clinics of North America 34 (4): 591–9, vii–viii. November 2007. doi:10.1016/j.ucl.2007.08.011. PMID 17983899. https://archive.org/details/sim_urologic-clinics-of-north-america_2007-11_34_4/page/591.
«Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation». The Journal of Sexual Medicine 8 (10): 2707–25. October 2011. doi:10.1111/j.1743-6109.2011.02386.x. PMID 21771283.
«New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder». Expert Opinion on Pharmacotherapy 12 (15): 2339–54. October 2011. doi:10.1517/14656566.2011.604030. PMID 21819273.
«Long-term pharmacotherapy for post-traumatic stress disorder». CNS Drugs 20 (6): 465–76. 2006. doi:10.2165/00023210-200620060-00003. PMID 16734498.
«Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment». The Journal of Clinical Psychiatry 61 (11): 863–7. November 2000. doi:10.4088/JCP.v61n1109. PMID 11105740. https://archive.org/details/sim_journal-of-clinical-psychiatry_2000-11_61_11/page/863.
«Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors». The Journal of Clinical Psychiatry 65 (10): 1365–71. October 2004. doi:10.4088/JCP.v65n1011. PMID 15491240. https://archive.org/details/sim_journal-of-clinical-psychiatry_2004-10_65_10/page/1365.
«Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors». Journal of Psychopharmacology 15 (3): 173–9. September 2001. doi:10.1177/026988110101500304. PMID 11565624.
«Effects of sertraline on autonomic and cognitive functions in healthy volunteers». Psychopharmacology 168 (3): 293–8. July 2003. doi:10.1007/s00213-003-1448-4. PMID 12692706. https://archive.org/details/sim_psychopharmacology_2003-07_168_3/page/293.
«Cognitive performance in depressed patients after chronic use of antidepressants». Psychopharmacology 185 (1): 84–92. March 2006. doi:10.1007/s00213-005-0274-2. PMID 16485140. https://archive.org/details/sim_psychopharmacology_2006-03_185_1/page/84.
«The influence of sertraline on attention and verbal memory in children and adolescents with anxiety disorders». Journal of Child and Adolescent Psychopharmacology 15 (4): 608–18. August 2005. doi:10.1089/cap.2005.15.608. PMID 16190792.
«Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man». Journal of Psychopharmacology 16 (3): 207–14. September 2002. doi:10.1177/026988110201600303. PMID 12236626.
«SSRI-associated bruxism: A systematic review of published case reports». Neurology. Clinical Practice 8 (2): 135–141. April 2018. doi:10.1212/CPJ.0000000000000433. PMID 29708207.
«Dystonias and dyskinesias of the jaw associated with the use of SSRIs». Human Psychopharmacology: Clinical and Experimental 10 (3): 215–219. 1995. doi:10.1002/hup.470100308.
«A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline». Clinical Therapeutics 21 (4): 643–58. April 1999. doi:10.1016/S0149-2918(00)88317-4. PMID 10363731.
«Post-SSRI Sexual Dysfunction: A Literature Review». Sexual Medicine Reviews 6 (1): 29–34. January 2018. doi:10.1016/j.sxmr.2017.07.002. PMID 28778697.
«Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis». JAMA Psychiatry 70 (4): 436–43. April 2013. doi:10.1001/jamapsychiatry.2013.684. PMID 23446732. https://archive.org/details/sim_jama-psychiatry_2013-04_70_4/page/436.
Lattimore, Keri A.; Donn, Steven M.; Kaciroti, Niko; Kemper, Alex R.; Neal, Charles R.; Vazquez, Delia M. (2005). «Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis». Journal of Perinatology 25 (9): 595–604. doi:10.1038/sj.jp.7211352. PMID 16015372.
«Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study». BMJ 339 (sep23 1): b3569. September 2009. doi:10.1136/bmj.b3569. PMID 19776103.
«Antidepressant use in pregnancy and the risk of cardiac defects». The New England Journal of Medicine 370 (25): 2397–407. June 2014. doi:10.1056/NEJMoa1312828. PMID 24941178.
«Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review». BMJ 330 (7488): 385. February 2005. doi:10.1136/bmj.330.7488.385. PMID 15718537.
«Suicidal antidepressant overdoses: a comparative analysis by antidepressant type». Journal of Medical Toxicology 4 (4): 238–50. December 2008. doi:10.1007/BF03161207. PMID 19031375.
«The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline». Journal of Clinical Psychopharmacology 18 (1): 55–61. February 1998. doi:10.1097/00004714-199802000-00009. PMID 9472843.
«CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline». Journal of Clinical Psychopharmacology 19 (2): 155–63. April 1999. doi:10.1097/00004714-199904000-00011. PMID 10211917.
«CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations». Journal of Clinical Pharmacology 40 (1): 58–66. January 2000. doi:10.1177/00912700022008702. PMID 10631623. https://archive.org/details/sim_journal-of-clinical-pharmacology_2000-01_40_1/page/58.
«Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers». Journal of Clinical Psychopharmacology 27 (1): 28–34. February 2007. doi:10.1097/00004714-200702000-00005. PMID 17224709. https://archive.org/details/sim_journal-of-clinical-psychopharmacology_2007-02_27_1/page/28.
«The effect of sertraline on methadone plasma levels in methadone-maintenance patients». The American Journal on Addictions 9 (1): 63–9. 2000. doi:10.1080/10550490050172236. PMID 10914294.
Murdoch, D; McTavish, D (October 1992). «Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.». Drugs 44 (4): 604–24. doi:10.2165/00003495-199244040-00007. PMID 1281075.
«Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [¹¹CDASB positron emission tomography study»]. The American Journal of Psychiatry 161 (5): 826–35. May 2004. doi:10.1176/appi.ajp.161.5.826. PMID 15121647. https://archive.org/details/sim_american-journal-of-psychiatry_2004-05_161_5/page/826.
«Pharmacological profile of antidepressants and related compounds at human monoamine transporters». European Journal of Pharmacology 340 (2–3): 249–58. December 1997. doi:10.1016/s0014-2999(97)01393-9. PMID 9537821.
«Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine». Biological Psychiatry 50 (5): 345–50. September 2001. doi:10.1016/s0006-3223(01)01145-3. PMID 11543737.
«The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders». CNS Drug Reviews 7 (1): 1–24. 2001. doi:10.1111/j.1527-3458.2001.tb00188.x. PMID 11420570.
«Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship». Central Nervous System Agents in Medicinal Chemistry 9 (3): 197–204. September 2009. doi:10.2174/1871524910909030197. PMID 20021354.
«Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered». Human Psychopharmacology 25 (3): 193–200. April 2010. doi:10.1002/hup.1106. PMID 20373470.
Sorbera, L.A.; Silvestre, J.; Castañer, J. (1999). «Igmesine Hydrochloride». Drugs of the Future 24 (2): 133. doi:10.1358/dof.1999.024.02.474038.
«Clinical trials with sigma ligands». Pharmacopsychiatry 37 Suppl 3: S214–20. November 2004. doi:10.1055/s-2004-832680. PMID 15547788.
«Pharmacological management of diarrhea». Gastroenterology Clinics of North America 39 (3): 495–507. September 2010. doi:10.1016/j.gtc.2010.08.003. PMID 20951914.
«Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes». Proceedings of the National Academy of Sciences of the United States of America 96 (23): 13512–7. November 1999. doi:10.1073/pnas.96.23.13512. PMID 10557352. Bibcode: 1999PNAS...9613512G.
«Relevance of endogenous 3α-reduced neurosteroids to depression and antidepressant action». Psychopharmacology 186 (3): 351–61. June 2006. doi:10.1007/s00213-005-0201-6. PMID 16249906. https://archive.org/details/sim_psychopharmacology_2006-06_186_3/page/351.
«Kinetics of allopregnanolone formation catalyzed by human 3α-hydroxysteroid dehydrogenase type III (AKR1C2)». Biochemistry 41 (45): 13451–9. November 2002. doi:10.1021/bi026109w. PMID 12416991.
«Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress». Frontiers in Neuroscience 5: 131. 2011. doi:10.3389/fnins.2011.00131. PMID 22164129.
«SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake». Current Opinion in Pharmacology 9 (1): 24–30. February 2009. doi:10.1016/j.coph.2008.12.006. PMID 19157982.
Warrington, SJ (December 1991). «Clinical implications of the pharmacology of sertraline.». International Clinical Psychopharmacology 6 Suppl 2: 11–21. doi:10.1097/00004850-199112002-00004. PMID 1806626.
«The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin». Clinical Pharmacology and Therapeutics 60 (5): 512–21. November 1996. doi:10.1016/S0009-9236(96)90147-2. PMID 8941024. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_1996-11_60_5/page/512.
«Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19». Clinical Pharmacology and Therapeutics 70 (1): 42–7. July 2001. doi:10.1067/mcp.2001.116513. PMID 11452243. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2001-07_70_1/page/42.
«5,8-Disubstituted 1-aminotetralins. A class of compounds with a novel profile of central nervous system activity». Journal of Medicinal Chemistry 16 (9): 1003–11. September 1973. doi:10.1021/jm00267a010. PMID 4795663.
See also: Mullin R (2006). «ACS Award for Team Innovation». Chemical & Engineering News 84 (5): 45–52. doi:10.1021/cen-v084n010.p045.
A short blurb on the history of sertraline, see: «The brains behind blockbusters». Science 309 (5735): 728. July 2005. doi:10.1126/science.309.5735.728. PMID 16051786.

drugbank.ca

«Sertraline». www.drugbank.ca. Ανακτήθηκε στις 25 Ιανουαρίου 2019.

drugs.com

«Sertraline (Zoloft) Use During Pregnancy». Drugs.com. 4 Μαΐου 2020. Ανακτήθηκε στις 17 Μαΐου 2020.
«Sertraline». Drugs.com. Ανακτήθηκε στις 11 Μαΐου 2015.
«Sertraline Hydrochloride». Drugs.com. The American Society of Health-System Pharmacists. Ανακτήθηκε στις 8 Ιανουαρίου 2018.
«Sertraline (Zoloft) Use During Pregnancy». Drugs.com. Ανακτήθηκε στις 7 Ιανουαρίου 2018.
«Zoloft Monograph for Professionals». Drugs.com. https://www.drugs.com/monograph/zoloft.html. Ανακτήθηκε στις 2018-09-16.
«Sertraline Oral Concentrate». drugs.com.

fda.gov

«Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)». FDA. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Σεπτεμβρίου 2007. Ανακτήθηκε στις 11 Ιουλίου 2008.
«Clinical review: relationship between antidepressant drugs and suicidality in adults» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. 17 Νοεμβρίου 2006. σελίδες 11–74. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 11 Ιουλίου 2008. Σφάλμα αναφοράς: Μη έγκυρη ετικέτα <ref> • όνομα " FDA2 " ορίζεται πολλές φορές με διαφορετικό περιεχόμενο
«Statistical Evaluation of Suicidality in Adults Treated with Antidepressants» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. 17 Νοεμβρίου 2006. σελίδες 75–140. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 11 Ιουλίου 2008. Σφάλμα αναφοράς: Μη έγκυρη ετικέτα <ref> • όνομα " FDA3 " ορίζεται πολλές φορές με διαφορετικό περιεχόμενο
Pfizer Inc. (30 Νοεμβρίου 2006). «Memorandum from Pfizer Global Pharmaceuticals Re: DOCKET: 2006N-0414 –"Suicidality data from adult antidepressant trials" Background package for December 13 Advisory Committee» (PDF). FDA DOCKET 2006N-0414. FDA. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 25 Ιουνίου 2008. Ανακτήθηκε στις 11 Ιουλίου 2008.
«Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers».

accessdata.fda.gov

Sertraline FDA Label Last updated May 2014
«Adderall XR Prescribing Information» (PDF). Medication Guide. United States Food and Drug Administration. Ανακτήθηκε στις 7 Οκτωβρίου 2013.

harvard.edu

adsabs.harvard.edu

«Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes». Proceedings of the National Academy of Sciences of the United States of America 96 (23): 13512–7. November 1999. doi:10.1073/pnas.96.23.13512. PMID 10557352. Bibcode: 1999PNAS...9613512G.

medicinescomplete.com

Brayfield, A, επιμ. (13 Αυγούστου 2013). Fluoxetine Hydrochloride. London, UK: Pharmaceutical Press. Ανακτήθηκε στις 27 Νοεμβρίου 2013.

medscape.com

«Issues In The Pharmacological Treatment of Obsessive-Compulsive Disorder: First-Line Treatment Options for OCD». medscape.com. 19 Ιουλίου 2007. Ανακτήθηκε στις 28 Ιουλίου 2009.

mhra.gov.uk

«Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants» (PDF). MHRA. Δεκεμβρίου 2004. Ανακτήθηκε στις 11 Ιουλίου 2008.

nih.gov

ncbi.nlm.nih.gov

«Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study». Drug Metabolism and Disposition 33 (2): 262–70. February 2005. doi:10.1124/dmd.104.002428. PMID 15547048.
«The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions». The Journal of Pharmacology and Experimental Therapeutics 316 (1): 336–48. January 2006. doi:10.1124/jpet.105.093229. PMID 16192315. https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2006-01_316_1/page/336.
«Clinical pharmacokinetics of sertraline». Clinical Pharmacokinetics 41 (15): 1247–66. 2002. doi:10.2165/00003088-200241150-00002. PMID 12452737.
«Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers». Journal of Clinical Psychopharmacology 24 (1): 4–10. February 2004. doi:10.1097/01.jcp.0000104908.75206.26. PMID 14709940.
«A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?». International Clinical Psychopharmacology 29 (4): 185–96. July 2014. doi:10.1097/YIC.0000000000000023. PMID 24424469.
«Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?». Psychotherapy and Psychosomatics 76 (1): 5–14. 2007. doi:10.1159/000096360. PMID 17170559.
«Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine». Health Technology Assessment 17 (7): 1–166. February 2013. doi:10.3310/hta17070. PMID 23438937.
«Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder». The American Journal of Psychiatry 160 (11): 1919–28. November 2003. doi:10.1176/appi.ajp.160.11.1919. PMID 14594734. https://archive.org/details/sim_american-journal-of-psychiatry_2003-11_160_11/page/1919.
«Pharmacologic treatment of obsessive-compulsive disorder: comparative studies». The Journal of Clinical Psychiatry. 58 58 Suppl 12: 18–22. 1997. PMID 9393392.
«Pharmacotherapies in the management of obsessive-compulsive disorder». Canadian Journal of Psychiatry 51 (7): 417–30. June 2006. doi:10.1177/070674370605100703. PMID 16838823. Αρχειοθετήθηκε από το πρωτότυπο στις 4 February 2010. https://www.webcitation.org/5nIDpfMnA?url=http://server03.cpa-apc.org:8080/Publications/Archives/CJP/2006/june/cjp-june-06-blier-IR.pdf.
Pediatric OCD Treatment Study (POTS) Team (October 2004). «Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial». JAMA 292 (16): 1969–76. doi:10.1001/jama.292.16.1969. PMID 15507582.
«A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder». The Journal of Clinical Psychiatry 67 (7): 1133–9. July 2006. doi:10.4088/JCP.v67n0717. PMID 16889458.
«Sertraline in the treatment of anxiety disorders». Depression and Anxiety 11 (4): 139–57. 2000. doi:10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C. PMID 10945134.
«Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies». Archives of Women's Mental Health 9 (3): 151–7. May 2006. doi:10.1007/s00737-005-0111-y. PMID 16292466.
«Efficacy and tolerability of second-generation antidepressants in social anxiety disorder». International Clinical Psychopharmacology 23 (3): 170–9. May 2008. doi:10.1097/YIC.0b013e3282f4224a. PMID 18408531.
«Pharmacotherapy of social anxiety disorder: what does the evidence tell us?». The Journal of Clinical Psychiatry 67 Suppl 12: 20–6. 2006. doi:10.1016/j.genhosppsych.2005.07.002. PMID 17092192.
«Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety». The New England Journal of Medicine 359 (26): 2753–66. December 2008. doi:10.1056/nejmoa0804633. PMID 18974308.
«Generalised anxiety disorder». BMJ Clinical Evidence 2011. October 2011. PMID 22030083.
«Selective serotonin reuptake inhibitors for premenstrual syndrome». The Cochrane Database of Systematic Reviews 6 (6): CD001396. June 2013. doi:10.1002/14651858.cd001396.pub3. PMID 23744611. PMC 7073417. https://researchspace.auckland.ac.nz/bitstream/2292/9631/4/14651858.CD001396.pub2.pdf.
«Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?». Drugs 62 (13): 1869–85. 2002. doi:10.2165/00003495-200262130-00004. PMID 12215058.
«Rational treatment choices for non-major depressions in primary care: an evidence-based review». Journal of General Internal Medicine 17 (4): 293–301. April 2002. doi:10.1046/j.1525-1497.2002.10350.x. PMID 11972726. PMC 1495030. https://archive.org/details/sim_journal-of-general-internal-medicine_2002-04_17_4/page/293.
«Pharmacologic treatment of rapid ejaculation: levels of evidence-based review». Current Clinical Pharmacology 1 (3): 243–54. September 2006. doi:10.2174/157488406778249352. PMID 18666749.
«Premature ejaculation: state of the art». The Urologic Clinics of North America 34 (4): 591–9, vii–viii. November 2007. doi:10.1016/j.ucl.2007.08.011. PMID 17983899. https://archive.org/details/sim_urologic-clinics-of-north-america_2007-11_34_4/page/591.
«Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation». The Journal of Sexual Medicine 8 (10): 2707–25. October 2011. doi:10.1111/j.1743-6109.2011.02386.x. PMID 21771283.
«New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder». Expert Opinion on Pharmacotherapy 12 (15): 2339–54. October 2011. doi:10.1517/14656566.2011.604030. PMID 21819273.
«Long-term pharmacotherapy for post-traumatic stress disorder». CNS Drugs 20 (6): 465–76. 2006. doi:10.2165/00023210-200620060-00003. PMID 16734498.
«Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment». The Journal of Clinical Psychiatry 61 (11): 863–7. November 2000. doi:10.4088/JCP.v61n1109. PMID 11105740. https://archive.org/details/sim_journal-of-clinical-psychiatry_2000-11_61_11/page/863.
«Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors». The Journal of Clinical Psychiatry 65 (10): 1365–71. October 2004. doi:10.4088/JCP.v65n1011. PMID 15491240. https://archive.org/details/sim_journal-of-clinical-psychiatry_2004-10_65_10/page/1365.
«Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors». Journal of Psychopharmacology 15 (3): 173–9. September 2001. doi:10.1177/026988110101500304. PMID 11565624.
«Effects of sertraline on autonomic and cognitive functions in healthy volunteers». Psychopharmacology 168 (3): 293–8. July 2003. doi:10.1007/s00213-003-1448-4. PMID 12692706. https://archive.org/details/sim_psychopharmacology_2003-07_168_3/page/293.
«Cognitive performance in depressed patients after chronic use of antidepressants». Psychopharmacology 185 (1): 84–92. March 2006. doi:10.1007/s00213-005-0274-2. PMID 16485140. https://archive.org/details/sim_psychopharmacology_2006-03_185_1/page/84.
«The influence of sertraline on attention and verbal memory in children and adolescents with anxiety disorders». Journal of Child and Adolescent Psychopharmacology 15 (4): 608–18. August 2005. doi:10.1089/cap.2005.15.608. PMID 16190792.
«[The effect of sertraline on cognitive functions in patients with obsessive-compulsive disorder]». Psychiatria Polska 36 (6 Suppl): 289–95. 2002. PMID 12647451.
«Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man». Journal of Psychopharmacology 16 (3): 207–14. September 2002. doi:10.1177/026988110201600303. PMID 12236626.
«SSRI-associated bruxism: A systematic review of published case reports». Neurology. Clinical Practice 8 (2): 135–141. April 2018. doi:10.1212/CPJ.0000000000000433. PMID 29708207.
«The effects of antidepressants on sexual functioning in depressed patients: a review». The Journal of Clinical Psychiatry. 62 62 Suppl 3: 22–34. 2001. PMID 11229450.
«A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline». Clinical Therapeutics 21 (4): 643–58. April 1999. doi:10.1016/S0149-2918(00)88317-4. PMID 10363731.
«Post-SSRI Sexual Dysfunction: A Literature Review». Sexual Medicine Reviews 6 (1): 29–34. January 2018. doi:10.1016/j.sxmr.2017.07.002. PMID 28778697.
«Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis». JAMA Psychiatry 70 (4): 436–43. April 2013. doi:10.1001/jamapsychiatry.2013.684. PMID 23446732. https://archive.org/details/sim_jama-psychiatry_2013-04_70_4/page/436.
Lattimore, Keri A.; Donn, Steven M.; Kaciroti, Niko; Kemper, Alex R.; Neal, Charles R.; Vazquez, Delia M. (2005). «Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis». Journal of Perinatology 25 (9): 595–604. doi:10.1038/sj.jp.7211352. PMID 16015372.
«Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study». BMJ 339 (sep23 1): b3569. September 2009. doi:10.1136/bmj.b3569. PMID 19776103.
«Antidepressant use in pregnancy and the risk of cardiac defects». The New England Journal of Medicine 370 (25): 2397–407. June 2014. doi:10.1056/NEJMoa1312828. PMID 24941178.
«Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review». BMJ 330 (7488): 385. February 2005. doi:10.1136/bmj.330.7488.385. PMID 15718537.
«Antidepressant discontinuation syndrome». American Family Physician 74 (3): 449–56. August 2006. PMID 16913164.
«Suicidal antidepressant overdoses: a comparative analysis by antidepressant type». Journal of Medical Toxicology 4 (4): 238–50. December 2008. doi:10.1007/BF03161207. PMID 19031375.
«The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline». Journal of Clinical Psychopharmacology 18 (1): 55–61. February 1998. doi:10.1097/00004714-199802000-00009. PMID 9472843.
«CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline». Journal of Clinical Psychopharmacology 19 (2): 155–63. April 1999. doi:10.1097/00004714-199904000-00011. PMID 10211917.
«CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations». Journal of Clinical Pharmacology 40 (1): 58–66. January 2000. doi:10.1177/00912700022008702. PMID 10631623. https://archive.org/details/sim_journal-of-clinical-pharmacology_2000-01_40_1/page/58.
«Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers». Journal of Clinical Psychopharmacology 27 (1): 28–34. February 2007. doi:10.1097/00004714-200702000-00005. PMID 17224709. https://archive.org/details/sim_journal-of-clinical-psychopharmacology_2007-02_27_1/page/28.
«The effect of sertraline on methadone plasma levels in methadone-maintenance patients». The American Journal on Addictions 9 (1): 63–9. 2000. doi:10.1080/10550490050172236. PMID 10914294.
Murdoch, D; McTavish, D (October 1992). «Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.». Drugs 44 (4): 604–24. doi:10.2165/00003495-199244040-00007. PMID 1281075.
«Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [¹¹CDASB positron emission tomography study»]. The American Journal of Psychiatry 161 (5): 826–35. May 2004. doi:10.1176/appi.ajp.161.5.826. PMID 15121647. https://archive.org/details/sim_american-journal-of-psychiatry_2004-05_161_5/page/826.
«Pharmacological profile of antidepressants and related compounds at human monoamine transporters». European Journal of Pharmacology 340 (2–3): 249–58. December 1997. doi:10.1016/s0014-2999(97)01393-9. PMID 9537821.
«Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine». Biological Psychiatry 50 (5): 345–50. September 2001. doi:10.1016/s0006-3223(01)01145-3. PMID 11543737.
«The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders». CNS Drug Reviews 7 (1): 1–24. 2001. doi:10.1111/j.1527-3458.2001.tb00188.x. PMID 11420570.
«Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship». Central Nervous System Agents in Medicinal Chemistry 9 (3): 197–204. September 2009. doi:10.2174/1871524910909030197. PMID 20021354.
«Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered». Human Psychopharmacology 25 (3): 193–200. April 2010. doi:10.1002/hup.1106. PMID 20373470.
«Clinical trials with sigma ligands». Pharmacopsychiatry 37 Suppl 3: S214–20. November 2004. doi:10.1055/s-2004-832680. PMID 15547788.
«Pharmacological management of diarrhea». Gastroenterology Clinics of North America 39 (3): 495–507. September 2010. doi:10.1016/j.gtc.2010.08.003. PMID 20951914.
«Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes». Proceedings of the National Academy of Sciences of the United States of America 96 (23): 13512–7. November 1999. doi:10.1073/pnas.96.23.13512. PMID 10557352. Bibcode: 1999PNAS...9613512G.
«Relevance of endogenous 3α-reduced neurosteroids to depression and antidepressant action». Psychopharmacology 186 (3): 351–61. June 2006. doi:10.1007/s00213-005-0201-6. PMID 16249906. https://archive.org/details/sim_psychopharmacology_2006-06_186_3/page/351.
«Kinetics of allopregnanolone formation catalyzed by human 3α-hydroxysteroid dehydrogenase type III (AKR1C2)». Biochemistry 41 (45): 13451–9. November 2002. doi:10.1021/bi026109w. PMID 12416991.
«Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress». Frontiers in Neuroscience 5: 131. 2011. doi:10.3389/fnins.2011.00131. PMID 22164129.
«SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake». Current Opinion in Pharmacology 9 (1): 24–30. February 2009. doi:10.1016/j.coph.2008.12.006. PMID 19157982.
Warrington, SJ (December 1991). «Clinical implications of the pharmacology of sertraline.». International Clinical Psychopharmacology 6 Suppl 2: 11–21. doi:10.1097/00004850-199112002-00004. PMID 1806626.
«Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro». Drug Metabolism and Disposition 27 (7): 763–6. July 1999. PMID 10383917.
«The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin». Clinical Pharmacology and Therapeutics 60 (5): 512–21. November 1996. doi:10.1016/S0009-9236(96)90147-2. PMID 8941024. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_1996-11_60_5/page/512.
«Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19». Clinical Pharmacology and Therapeutics 70 (1): 42–7. July 2001. doi:10.1067/mcp.2001.116513. PMID 11452243. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2001-07_70_1/page/42.
«Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites». The Journal of Pharmacology and Experimental Therapeutics 283 (3): 1305–22. December 1997. PMID 9400006.
«5,8-Disubstituted 1-aminotetralins. A class of compounds with a novel profile of central nervous system activity». Journal of Medicinal Chemistry 16 (9): 1003–11. September 1973. doi:10.1021/jm00267a010. PMID 4795663.
A short blurb on the history of sertraline, see: «The brains behind blockbusters». Science 309 (5735): 728. July 2005. doi:10.1126/science.309.5735.728. PMID 16051786.

pubmedcentral.nih.gov

«A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?». International Clinical Psychopharmacology 29 (4): 185–96. July 2014. doi:10.1097/YIC.0000000000000023. PMID 24424469.
«Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine». Health Technology Assessment 17 (7): 1–166. February 2013. doi:10.3310/hta17070. PMID 23438937.
«Efficacy and tolerability of second-generation antidepressants in social anxiety disorder». International Clinical Psychopharmacology 23 (3): 170–9. May 2008. doi:10.1097/YIC.0b013e3282f4224a. PMID 18408531.
«Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety». The New England Journal of Medicine 359 (26): 2753–66. December 2008. doi:10.1056/nejmoa0804633. PMID 18974308.
«Generalised anxiety disorder». BMJ Clinical Evidence 2011. October 2011. PMID 22030083.
«Selective serotonin reuptake inhibitors for premenstrual syndrome». The Cochrane Database of Systematic Reviews 6 (6): CD001396. June 2013. doi:10.1002/14651858.cd001396.pub3. PMID 23744611. PMC 7073417. https://researchspace.auckland.ac.nz/bitstream/2292/9631/4/14651858.CD001396.pub2.pdf.
«Rational treatment choices for non-major depressions in primary care: an evidence-based review». Journal of General Internal Medicine 17 (4): 293–301. April 2002. doi:10.1046/j.1525-1497.2002.10350.x. PMID 11972726. PMC 1495030. https://archive.org/details/sim_journal-of-general-internal-medicine_2002-04_17_4/page/293.
«SSRI-associated bruxism: A systematic review of published case reports». Neurology. Clinical Practice 8 (2): 135–141. April 2018. doi:10.1212/CPJ.0000000000000433. PMID 29708207.
«Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study». BMJ 339 (sep23 1): b3569. September 2009. doi:10.1136/bmj.b3569. PMID 19776103.
«Antidepressant use in pregnancy and the risk of cardiac defects». The New England Journal of Medicine 370 (25): 2397–407. June 2014. doi:10.1056/NEJMoa1312828. PMID 24941178.
«Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review». BMJ 330 (7488): 385. February 2005. doi:10.1136/bmj.330.7488.385. PMID 15718537.
«Suicidal antidepressant overdoses: a comparative analysis by antidepressant type». Journal of Medical Toxicology 4 (4): 238–50. December 2008. doi:10.1007/BF03161207. PMID 19031375.
«The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders». CNS Drug Reviews 7 (1): 1–24. 2001. doi:10.1111/j.1527-3458.2001.tb00188.x. PMID 11420570.
«Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes». Proceedings of the National Academy of Sciences of the United States of America 96 (23): 13512–7. November 1999. doi:10.1073/pnas.96.23.13512. PMID 10557352. Bibcode: 1999PNAS...9613512G.
«Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress». Frontiers in Neuroscience 5: 131. 2011. doi:10.3389/fnins.2011.00131. PMID 22164129.
«SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake». Current Opinion in Pharmacology 9 (1): 24–30. February 2009. doi:10.1016/j.coph.2008.12.006. PMID 19157982.

nps.org.au

«Sertraline Sandoz Tablet». NPS MedicineWise. Ανακτήθηκε στις 16 Σεπτεμβρίου 2018.

psychcentral.com

Grohol, John M. (12 Οκτωβρίου 2017). «Top 25 Psychiatric Medications for 2016». Psych Central. Ανακτήθηκε στις 22 Οκτωβρίου 2018.

unc.edu

pdsp.unc.edu

«PDSP K_i Database». Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Ανακτήθηκε στις 14 Αυγούστου 2017.

uptodate.com

«Side effects of antidepressant medications». UpToDate. Wolters Kluwer Health. Ανακτήθηκε στις 27 Νοεμβρίου 2013.

web.archive.org

«Sertraline Hydrochloride - Drug Usage Statistics». ClinCalc. 23 Δεκεμβρίου 2019. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Απριλίου 2020. Ανακτήθηκε στις 11 Απριλίου 2020.
«Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)». FDA. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Σεπτεμβρίου 2007. Ανακτήθηκε στις 11 Ιουλίου 2008.
«Clinical review: relationship between antidepressant drugs and suicidality in adults» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. 17 Νοεμβρίου 2006. σελίδες 11–74. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 11 Ιουλίου 2008. Σφάλμα αναφοράς: Μη έγκυρη ετικέτα <ref> • όνομα " FDA2 " ορίζεται πολλές φορές με διαφορετικό περιεχόμενο
«Statistical Evaluation of Suicidality in Adults Treated with Antidepressants» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. 17 Νοεμβρίου 2006. σελίδες 75–140. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 11 Ιουλίου 2008. Σφάλμα αναφοράς: Μη έγκυρη ετικέτα <ref> • όνομα " FDA3 " ορίζεται πολλές φορές με διαφορετικό περιεχόμενο
Pfizer Inc. (30 Νοεμβρίου 2006). «Memorandum from Pfizer Global Pharmaceuticals Re: DOCKET: 2006N-0414 –"Suicidality data from adult antidepressant trials" Background package for December 13 Advisory Committee» (PDF). FDA DOCKET 2006N-0414. FDA. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 25 Ιουνίου 2008. Ανακτήθηκε στις 11 Ιουλίου 2008.

webcitation.org

«Pharmacotherapies in the management of obsessive-compulsive disorder». Canadian Journal of Psychiatry 51 (7): 417–30. June 2006. doi:10.1177/070674370605100703. PMID 16838823. Αρχειοθετήθηκε από το πρωτότυπο στις 4 February 2010. https://www.webcitation.org/5nIDpfMnA?url=http://server03.cpa-apc.org:8080/Publications/Archives/CJP/2006/june/cjp-june-06-blier-IR.pdf.